NewsRx

Search our medical news database

Cancer Gene Therapy

Targeted HSV Vector Delivers Punch to Hepatoma Tumors

Published in Gene Therapy Weekly, May 17th, 1999

A new therapeutic strategy for tumor therapy involves targeting viral vectors.

S.I. Miyatake and colleagues from the Kyoto University Hospital, Japan and Georgetown University Medical Center, Washington, DC, analyzed a hepatoma-specific viral vector incorporating the herpes simplex virus (HSV) both in vitro and in vivo ("Hepatoma-Specific Antitumor Activity of an Albumin Enhancer/Promoter Regulated Herpes Simplex Virus In Vivo," Gene Therapy, April 1999;6(4):564-72).

"We describe an alternative approach to virus-mediated gene therapy, where HSV replication and associated cytotoxicity are limited to a specific cell-type by the regulated expression of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook